Table 1.
Number of cases (%) | ρ Value | ||
---|---|---|---|
Pulmonary (n = 294) | Extrapulmonary (n = 103) | ||
Age (years) | < 0.01 | ||
0-15 | 36 (12.24) | 15 (14.56) | |
16-30 | 87 (29.59) | 25 (24.27) | |
31-45 | 68 (23.13) | 19 (18.45) | |
46-60 | 33 (11.22) | 27 (26.21) | |
≥ 61 | 18 (6.12) | 11 (10.68) | |
Unknown | 52 (17.69) | 6 (5.83) | |
Gender | 0.11 | ||
Male | 183 (62.24) | 55 (53.40) | |
Female | 111 (37.76) | 48 (46.60) | |
Drug Resistance | 0.37 | ||
Any Drug Resistance | 88 (29.93) | 26 (25.25) | |
Susceptible | 206 (70.07) | 77 (74.76) | |
IS6110 Copies | 0.66 | ||
≤ 5 copies | 75 (25.51) | 24 (23.30) | |
> 5 copies | 219 (74.49) | 79 (76.70) | |
Spoligotype Superfamily | 0.20 | ||
T | 131 (44.56) | 53 (51.46) | |
Lam | 63 (21.43) | 14 (13.59) | |
H | 43 (14.63) | 13 (12.62) | |
Undefined | 35 (11.90) | 18 (17.48) | |
Other | 22 (7.48) | 5 (4.55) | |
Cluster | < 0.01 | ||
Clustered | 112 (38.10) | 20 (19.42) | |
Unique | 182 (61.90) | 83 (80.58) |